WAVE Life Sciences Ltd. Sees a 23% Stock Price Surge Over the Past Three Months

Published on 23 Aug 2023 on GuruFocus.com via Yahoo Finance

WAVE Life Sciences Ltd. Sees a 23% Stock Price Surge Over the Past Three Months

WAVE Life Sciences Ltd. (NASDAQ:WVE), a preclinical biopharmaceutical company, has seen a significant increase in its stock price over the past three months. The company's market cap currently stands at $468.19 million, with a stock price of $4.73, marking a 23.45% increase from its price three months ago at $3.83. Over the past week, the stock price has also seen a gain of 3.62%.

GF Value and Valuation

Warning! GuruFocus has detected 4 Warning Signs with WVE. Click here to check it out. WVE 30-Year Financial DataThe intrinsic value of WVE

Read the rest of the article

NASDAQ.VIRX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

News

WAVE Life Sciences Ltd. Sees a 23% Stock Price Surge Over the Past Three Months

NASDAQ.VIRX price evolution

Want to become a better investor?

Masimo To Rally More Than 13%? Here Are 5 Top Analyst Forecasts For Friday -...

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.77% By...

US Stocks To Open Lower As Index Future Decline: Analysts Remain Upbeat About...

Viracta Therapeutics Explores Strategic Options After NAVAL-1 Closure

Castellum, Viracta Therapeutics And 3 Stocks To Watch Heading Into Friday...

Deal Dispatch: Party City Wraps Up, Big Lots Goes Bust, The Container Store...

Viracta Therapeutics Inc (VIRX) Reports Q3 2023 Financial Results Amid Clinical Advances

WAVE Life Sciences Ltd. Sees a 23% Stock Price Surge Over the Past Three Months

Viracta Therapeutics Says Pivotal Cancer Trial Achieves Efficacy Threshold For Expansion Into Next...

Has IMARA (IMRA) Outpaced Other Medical Stocks This Year?